首页> 外文期刊>Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology >Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST).
【24h】

Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST).

机译:脑卒中的严重程度,早期恢复和结果均与脑卒中的临床分类有关:“急性缺血性脑卒中试验中的替扎肝素”(TAIST)数据。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Baseline severity and clinical stroke syndrome (Oxford Community Stroke Project, OCSP) classification are predictors of outcome in stroke. We used data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST) to assess the relationship between stroke severity, early recovery, outcome and OCSP syndrome. METHODS: TAIST was a randomised controlled trial assessing the safety and efficacy of tinzaparin versus aspirin in 1484 patients with acute ischaemic stroke. Severity was measured as the Scandinavian Neurological Stroke Scale (SNSS) at baseline and days 4, 7 and 10, and baseline OCSP clinical classification recorded: total anterior circulation infarct (TACI), partial anterior circulation infarct (PACI), lacunar infarct (LACI) and posterior circulation infarction (POCI). Recovery was calculated as change in SNSS from baseline at day 4 and 10. The relationship between stroke syndrome and SNSS at days 4 and 10, and outcome (modified Rankin Scale at 90 days) were assessed. RESULTS: Stroke severity was significantly different between TACI (most severe) and LACI (mildest) at all four time points (p<0.001), with no difference between PACI and POCI. The largest change in SNSS score occurred between baseline and day 4; improvement was least in TACI (median 2 units), compared to other groups (median 3 units) (p<0.001). If SNSS did not improve by day 4, then early recovery and late functional outcome tended to be limited irrespective of clinical syndrome (SNSS, baseline: 31, day 10: 32; mRS, day 90: 4); patients who recovered early tended to continue to improve and had better functional outcome irrespective of syndrome (SNSS, baseline: 35, day 10: 50; mRS, day 90: 2). CONCLUSIONS: Although functional outcome is related to baseline clinical syndrome (best with LACI, worst with TACI), patients who improve early have a more favourable functional outcome, irrespective of their OCSP syndrome. Hence, patients with a TACI syndrome may still achieve a reasonable outcome if early recovery occurs.
机译:简介:基线严重程度和临床卒中综合征(牛津社区卒中计划,OCSP)分类是卒中预后的预测指标。我们使用来自“急性缺血性卒中试验中的替扎肝素”(TAIST)的数据来评估卒中严重程度,早期恢复,预后和OCSP综合征之间的关系。方法:TAIST是一项随机对照试验,评估替扎肝素与阿司匹林在1484例急性缺血性中风患者中的安全性和有效性。在基线和第4、7和10天时以斯堪的纳维亚神经中风量表(SNSS)来衡量严重程度,并记录基线OCSP临床分类:总前循环梗塞(TACI),部分前循环梗塞(PACI),腔隙性梗塞(LACI)和后循环梗塞(POCI)。以第4天和第10天从基线开始的SNSS的变化计算恢复率。评估第4天和第10天的卒中综合征和SNSS之间的关系以及结局(90天时的兰金量表修订)。结果:在所有四个时间点,TACI(最严重)和LACI(最轻)之间的卒中严重程度均存在显着差异(p <0.001),而PACI和POCI之间无差异。 SNSS得分的最大变化发生在基线和第4天之间;与其他组(中位数3个单位)相比,TACI(中位数2个单位)的改善最小(p <0.001)。如果SNSS到第4天仍未改善,则不论临床综合征如何,早期恢复和晚期功能结局均受到限制(SNSS,基线:31,第10天:32; mRS,第90:4);早期恢复的患者倾向于继续改善,并且无论综合征如何都具有更好的功能结局(SNSS,基线:35,第10天:50; mRS,第90:2天)。结论:尽管功能预后与基线临床综合征相关(LACI最佳,TACI最差),但早期改善的患者无论其OCSP综合征如何,其功能预后均较理想。因此,如果能够早日康​​复,则患有TACI综合征的患者仍可能取得合理的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号